Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Metabolites|May 26, 2023
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic OptionsBilal Bashir, Jan H Ho, Paul Downie, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2024
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National RegistryBilal Bashir, Paul Downie, Natalie Forrester, et al.
Science Advances|November 12, 2025
Identification and characterization of botulinum neurotoxin-like two-component toxins in Paeniclostridium ghoniiPyung-Gang Lee, Linxiang Yin, Xin Wei, et al.
Atherosclerosis|March 6, 2024
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)Bilal Bashir, See Kwok, Anthony S Wierzbicki, et al.
Genetics in Medicine Open|September 8, 2025
Rare variant genetic landscape of familial chylomicronemia syndrome (FCS) in the United KingdomBilal Bashir, Natalie Forrester, Paul Downie, et al.
The Journal of Rheumatology|March 3, 2019
Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017Toby O Smith, Michael Mansfield, Gillian A Hawker, et al.
BMC Nephrology|July 1, 2020
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocolKim M Gooding, Chrysta Lienczewski, Massimo Papale, et al.
Pain|March 17, 2021
Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent painNadia Soliman, Simon Haroutounian, Andrea G Hohmann, et al.
Pageof 4